Union Minister of State (Independent Charge) for Science & Technology and Earth Sciences, and Minister of State for the PMO, Department of Space, and Department of Atomic Energy, Dr Jitendra Singh, emphasised that early detection and affordability remain the two biggest challenges in addressing genetic and rare diseases. He stated that India is now both scientifically and economically equipped to confront complex health challenges through genomics, biotechnology, and preventive healthcare.
Visit to CDFD Marks Major Capacity-Building Initiatives
Dr Jitendra Singh made these remarks during his visit to the DBT–BRIC Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad. During the visit, he laid the foundation stone for the National Skill Development Centre, SAMARTH, and inaugurated the iDeA-NA BRIC-CDFD Technology Incubator, underscoring the government’s focus on skill development and innovation.
Shift from Infectious Diseases to Precision Medicine
Highlighting India’s evolving healthcare landscape, the Minister noted that while the country once focused largely on infectious diseases, it has now entered a new era where molecular diagnostics, genome sequencing, and personalised medicine are central to healthcare delivery. He added that institutions such as CDFD play a critical role in translating laboratory research into real-world clinical outcomes.
Biotechnology Receives Unprecedented Policy Priority
Turning to policy direction, Dr Jitendra Singh said that biotechnology and healthcare have received unprecedented attention under the leadership of Prime Minister Narendra Modi. He recalled the announcement of the Bio-E3 Policy during the Independence Day address from the Red Fort, describing it as a catalyst that has energised scientists, startups, and young innovators across the country.
Genomics-Led Initiatives Prepare Healthcare for the Future
As reported by pib.gov.in, the Minister further observed that India is making rapid strides in genomics-led programmes, including large-scale genome sequencing, paediatric genetic disease initiatives, and pioneering work in areas such as haemophilia. These efforts, he said, are preparing the healthcare system for an era of personalised treatment, where patients with similar conditions may require different therapeutic strategies.
National Policy for Rare Diseases Signals Strategic Shift
Referring to rare diseases, Dr Jitendra Singh highlighted that the introduction of India’s first National Policy for Rare Diseases in 2021 marked a significant shift in the government’s approach. While early detection is essential, he stressed that long-term treatment must also be made affordable to reduce the burden on affected families.
Integrating Wellness with Modern Medicine
The Minister also spoke about the integrated healthcare model being promoted by the government. He pointed to the institutionalisation of traditional systems through the Ministry of Ayush and the global recognition of yoga as a preventive health practice. According to him, evidence-based integration of wellness approaches with modern medicine has yielded encouraging results in managing lifestyle and metabolic disorders.
Strengthening Research, Outreach, and Public Engagement
During his visit, Dr Jitendra Singh reviewed ongoing research and innovation activities at CDFD and appreciated its genome sequencing programmes and public outreach initiatives. He emphasised that communicating science in an accessible language, particularly to young people, is vital for building trust and sustained interest in biotechnology.
Rising Bio-Economy and Startup Ecosystem
Highlighting India’s expanding bio-economy, the Minister noted a sharp increase in the number of biotechnology startups and the sector’s growing contribution to the economy. He added that the creation of the Biotechnology Research and Innovation Council (BRIC) has improved institutional coordination, enabling high-impact research and stronger industry collaboration.
India’s Leadership in Vaccines and Preventive Healthcare
Moreover, Dr Jitendra Singh underscored India’s global leadership in vaccines and preventive healthcare. He said that indigenous innovations are now being deployed across the country and shared internationally, reinforcing India’s role in strengthening global health security.
Investing in Youth and Prevention for a Healthier India
Concluding his address, the Minister highlighted that nearly 70 per cent of India’s population is below the age of 40, making early diagnosis and preventive healthcare a national priority. Expressing satisfaction with the work being carried out at CDFD, he said that institutions like these are playing a vital role in building a healthier, stronger, and future-ready India.